Study of Erlotinib and Metformin in Triple Negative Breast Cancer
This study is currently recruiting participants.
Verified July 2012 by Columbia University
Sponsor:
Matthew A. Maurer
Collaborators:
Susan G. Komen Breast Cancer Foundation
Astellas Pharma Inc
Information provided by (Responsible Party):
Matthew A. Maurer, Columbia University
ClinicalTrials.gov Identifier:
NCT01650506
First received: July 24, 2012
Last updated: July 25, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2015 |
| Estimated Primary Completion Date: | June 2014 (Final data collection date for primary outcome measure) |